Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-16 4:23 pm Purchase | 2022-09-16 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 14,301,551 23.300% | 622,496 (+4.55%) | Filing History |
| 2022-09-16 2:27 pm Purchase | 2022-09-14 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,071,703 9.600% | 484,496 (+8.67%) | Filing History |
| 2022-08-15 4:59 pm Sale | 2022-08-15 | 13G | Edgewise Therapeutics, Inc. EWTX | RA Capital Management, L.P. | 0 0.000% | -2,613,623 (Position Closed) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | VIKING GLOBAL INVESTORS LP | 2,727,249 5.500% | -625,032 (-18.64%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | RA Capital Management, L.P. | 2,613,623 5.300% | 2,613,623 (New Position) | Filing History |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 3,565,901 7.230% | 974,987 (+37.63%) | Filing History |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 2,500,099 5.071% | 2,500,099 (New Position) | Filing History |
| 2022-01-13 4:28 pm Purchase | 2022-01-03 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,489,284 5.000% | 30,761 (+1.25%) | Filing History |
| 2022-01-13 4:27 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,458,523 5.000% | 3,199 (+0.13%) | Filing History |
| 2021-07-12 4:07 pm Purchase | 2021-07-01 | 13G | Edgewise Therapeutics, Inc. EWTX | Citadel Advisors LLC | 2,455,324 5.000% | 2,455,324 (New Position) | Filing History |
| 2021-05-18 4:08 pm Purchase | 2021-05-13 | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,590,914 5.260% | 2,590,914 (New Position) | Filing History |
| 2021-04-30 6:44 pm Purchase | 2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX | U.S. Venture Partners XI L.P. | 3,489,168 7.100% | 3,489,168 (New Position) | Filing History |
| 2021-04-07 6:00 pm Purchase | 2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 13,679,055 27.800% | 13,679,055 (New Position) | Filing History |
| 2021-04-05 3:20 pm Purchase | 2021-03-26 | 13G | Edgewise Therapeutics, Inc. EWTX | VIKING GLOBAL INVESTORS LP | 3,352,281 7.000% | 3,352,281 (New Position) | Filing History |
| 2021-03-31 4:31 pm Purchase | 2020-03-25 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,587,207 11.400% | 5,587,207 (New Position) | Filing History |
| 2021-03-30 3:40 pm Purchase | 2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Deerfield Mgmt, L.P. | 3,933,137 8.270% | 3,933,137 (New Position) | Filing History |